Search

everythinglearnresearchcommunity

for

Search:↓

Targeting NETs may help reduce fibrosis in Crohn's disease.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

CD4+ skin cells may be precursors to basal cell carcinoma.

Rice bran extract and low-frequency electromagnetic fields together may help treat vitiligo and white hair.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Platelet-based therapies using a patient's own blood show promise for skin and hair regeneration but require more research for confirmation.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

AcSDKP may help prevent skin and hair aging and promote their growth.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Scientists can control how skin stem cells divide by using different treatments.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Topical valproate can effectively promote hair growth.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

Aging causes hair loss and graying due to stem cell decline and changes in cell behavior and communication.